GMAB 6-K: SEC filing

Genmab A/S

Filed with the SEC on · accession 0001434265-26-000148

GMAB filed a 6-K (foreign company report) with the SEC on Nov 10, 2026. Genmab A/S filed a Form 6-K with the SEC on November 10, 2026, attaching a company announcement dated the same day.

Summary of the filing

Genmab A/S filed a Form 6-K with the SEC on November 10, 2026, attaching a company announcement dated the same day. The filing itself contains no substantive financial or operational details beyond the exhibit reference.

Key details

RegistrantGenmab A/S
Executive vice president & chief financial officerAnthony Pagano

✦ Ask GOAX AI about this filing — what it means for GMAB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GMAB?

Click here

Frequently asked questions

What did GMAB file with the SEC on Nov 10, 2026?

GMAB filed a 6-K (SEC filing). Genmab A/S filed a Form 6-K with the SEC on November 10, 2026, attaching a company announcement dated the same day. The filing itself contains no substantive financial or operational details beyond the exhibit reference.

How do I read a 6-K?

How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.

Other GMAB SEC filings

Get alerts when GMAB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days